BB-TL1A-VIAL-HLE

· Vial Australia Pty Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BB-TL1A-VIAL-HLE, covering 2026-01-22 to 2026-01-22. Get the full timeline:

Most recent: Clinical Trial Update: A First-in-Human Study of BB-TL1A-VIAL-HLE in Healthy Adults and People With Ulcerative Colitis [Phase 1]